Platelet Rich Plasma Injection in Pilon Fractures

Completed · Not applicable

Conditions studied: Fracture

In brief

Patients who sustain broken ankles have a very high risk of developing arthritis soon after injury (within 2 years). This arthritis can cause increased pain and a decrease level of function, especially if the injury occurs at an early age. During and shortly after ankle injury, there is an inflammatory chemical process that takes place in the ankle that can cause damage to the cartilage in the ankle joint. The investigators want to use what is called Platelet Rich Plasma (PRP), which is produced from a small amount of the patient's own blood, to inject into the injured ankle to see if they can decrease the inflammation that happens after the injury and to see if they can decrease arthritis.

Key facts

Study ID

NCT02481869

Run by

University of Missouri-Columbia

People needed

11

Starts

2015-06-01

Expected to finish

2019-11-01

Last updated by the study team

2021-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Closed unilateral pilon fracture

You may not qualify if…

• Patients who are younger than 18 years of age
• Open pilon fracture
• Patients with contralateral lower extremity injury
• Patients unable to comply with the follow-up appointments
• Patients who had previous ankle injury to the currently injured ankle
• Patients who are pregnant
• Prisoners

Where it is running

• University of Missouri — Columbia, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.